MODEX THERAPEUTICS, INC
Key facts
| Awarded supplier / winner | MODEX THERAPEUTICS, INC |
|---|---|
| Registration / LEI number | US-UEI: CDVMNSMRDTW8 |
| Entity type | Legal entity / organization |
| Country | United States |
| Confirmed contracts | 1 |
| Awarded volume | $103,516,903 (1) |
| Checked | |
| Source | USAspending.gov Federal Contract Awards ↗ |
Confirmed contract awards (1)
| Award date | Tenders | Buyer | CPV | Awarded contract amount | Source |
|---|---|---|---|---|---|
| Sep 27, 2023 | ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA. | Office of Assistant Secretary for Preparedness and Response | — | $103,516,903 | USAspending.gov Federal Contract Awards ↗ |
Contracting buyers
| Buyer | Country | Confirmed contracts | Awarded volume |
|---|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | United States | 1 | $103,516,903 (1) |
Award dynamics by period
| Period | Confirmed contracts | Awarded volume |
|---|---|---|
2023-09 | 1 | $103,516,903 (1) |
Public business contacts
United States
Checked:
Sources
The original notice takes precedence. Its status and conditions can change after collection. Hash: 9d15286398ddf7f8
